- Home
- ASND vs GL Comparison
ASND vs GL Comparison
Compare ASND & GL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- GL
- Stock Information
- Founded
- ASND 2006
- GL 1900
- Country
- ASND Denmark
- GL United States
- Employees
- ASND N/A
- GL N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- GL Life Insurance
- Sector
- ASND Health Care
- GL Finance
- Exchange
- ASND Nasdaq
- GL Nasdaq
- Market Cap
- ASND 10.6B
- GL 9.9B
- IPO Year
- ASND 2015
- GL N/A
- Fundamental
- Price
- ASND $170.86
- GL $124.30
- Analyst Decision
- ASND Strong Buy
- GL Buy
- Analyst Count
- ASND 16
- GL 11
- Target Price
- ASND $218.19
- GL $137.73
- AVG Volume (30 Days)
- ASND 435.4K
- GL 468.3K
- Earning Date
- ASND 05-01-2025
- GL 07-23-2025
- Dividend Yield
- ASND N/A
- GL 0.87%
- EPS Growth
- ASND N/A
- GL 17.62
- EPS
- ASND N/A
- GL 12.31
- Revenue
- ASND $398,509,511.00
- GL $5,842,352,000.00
- Revenue This Year
- ASND $75.05
- GL $7.79
- Revenue Next Year
- ASND $78.14
- GL $4.99
- P/E Ratio
- ASND N/A
- GL $10.11
- Revenue Growth
- ASND 12.06
- GL 5.41
- 52 Week Low
- ASND $111.09
- GL $80.36
- 52 Week High
- ASND $183.00
- GL $133.76
- Technical
- Relative Strength Index (RSI)
- ASND 52.37
- GL 59.78
- Support Level
- ASND $166.84
- GL $121.18
- Resistance Level
- ASND $180.78
- GL $123.69
- Average True Range (ATR)
- ASND 5.57
- GL 1.66
- MACD
- ASND -0.53
- GL 0.46
- Stochastic Oscillator
- ASND 38.59
- GL 96.28
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About GL Globe Life Inc.
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.